Mkts

Castle Biosciences, Inc.

NASDAQ: CSTL
$33.38+0.40 (+1.21%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
32.3434.09
52-week range
17.7244.28
Today
Open33.26
Previous close33.38
Volume—
Valuation
Market cap1.01B
P/E ratio—
EPS (TTM)-0.65
Income & risk
Dividend / yield—
Beta1.02
Avg volume408.0K
Discussion

CSTL News

Stories mentioning CSTL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue83,67987,01083,04386,18887,98886,31185,78287,002
Cost of Goods Sold20,53318,31518,70417,62616,38316,18315,60914,519
Gross Profit63,14668,69564,33968,56271,60570,12870,17372,483
Operating Expenses
Research & Development14,42813,51512,96012,78712,58811,77312,32314,136
Sales General & Admin64,89956,73155,90758,06558,62049,96550,49951,088
Total Operating Expenses
Operating Income (Loss)(18,407)(3,827)(6,804)(4,251)(27,928)4,0505,0795,012
Interest Income2,5452,8962,8332,9443,0993,3723,4043,144
Interest Expense9.008.00192.00216.00
Other Expense(439.00)48.000.000.00
Pretax Income
Tax Provision109.00(382.00)115.00(4,666)(423.00)(1,705)6,013(1,034)
Net Income (Loss)(14,522)(2,332)(501.00)4,523(25,848)9,5902,2698,920
Earnings Per Share (Basic)(0.49)(0.08)(0.02)0.16(0.90)0.350.080.32
Earnings Per Share (Diluted)(0.49)(0.08)(0.02)0.15(0.90)0.330.080.31
Weighted Average Shares Outstanding (Basic)29,88928,98629,07328,91428,60927,77627,84027,646
Weighted Average Shares Outstanding (Diluted)29,88928,98629,07329,54528,60929,25529,40128,738

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CSTL

Castle Biosciences, Inc. (NASDAQ: CSTL) is a stock listed on the Nasdaq Stock Market under the ticker symbol CSTL. It last traded at $33.38 (Nov 18, 2026, 4:00 PM ET), up 1.2% on the day. That gives Castle Biosciences a market capitalisation of $1.0B.

Over the past 52 weeks CSTL has traded between $17.72 and $44.28.

Revenue for the quarter ended Mar 31, 2026 was $83.7M; a net loss of $14.5M. Revenue was down 4.9% from $88.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$83.7M-$14.5M-17.4%
Dec 31, 2025$87.0M-$2.3M-2.7%
Sep 30, 2025$83.0M-$501.0K-0.6%
Jun 30, 2025$86.2M$4.5M5.2%

From Castle Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…